| CD71+ erythroid suppressor cells promote fetomaternal tolerance through arginase-2 and PDL-1 C Delyea, N Bozorgmehr, P Koleva, G Dunsmore, S Shahbaz, V Huang, ... The Journal of Immunology 200 (12), 4044-4058, 2018 | 73 | 2018 |
| CD71+ VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-β S Shahbaz, N Bozorgmehr, P Koleva, A Namdar, J Jovel, RA Fava, ... PLoS biology 16 (12), e2006649, 2018 | 64 | 2018 |
| Erythroid suppressor cells compromise neonatal immune response against Bordetella pertussis G Dunsmore, N Bozorgmehr, C Delyea, P Koleva, A Namdar, S Elahi The Journal of Immunology 199 (6), 2081-2095, 2017 | 62 | 2017 |
| Galectin-9, a player in cytokine release syndrome and a surrogate diagnostic biomarker in SARS-CoV-2 infection N Bozorgmehr, S Mashhouri, E Perez Rosero, L Xu, S Shahbaz, W Sligl, ... MBio 12 (3), 10.1128/mbio. 00384-21, 2021 | 56 | 2021 |
| The quality of SARS-CoV-2–specific T cell functions differs in patients with mild/moderate versus severe disease, and T cells expressing coinhibitory receptors are highly activated S Shahbaz, L Xu, W Sligl, M Osman, N Bozorgmehr, S Mashhouri, ... The Journal of Immunology 207 (4), 1099-1111, 2021 | 47 | 2021 |
| Expanded antigen-experienced CD160+ CD8+ effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia N Bozorgmehr, I Okoye, O Oyegbami, L Xu, A Fontaine, N Cox-Kennett, ... Journal for immunotherapy of cancer 9 (4), 2021 | 31 | 2021 |
| Depletion of polyfunctional CD26highCD8+ T cells repertoire in chronic lymphocytic leukemia N Bozorgmehr, M Hnatiuk, AC Peters, S Elahi Experimental Hematology & Oncology 12 (1), 13, 2023 | 13 | 2023 |
| CD71+ erythroid cells suppress T-cell effector functions and predict immunotherapy outcomes in patients with virus-associated solid tumors N Bozorgmehr, I Okoye, S Mashhouri, J Lu, P Koleva, J Walker, S Elahi Journal for Immunotherapy of Cancer 11 (5), 2023 | 9 | 2023 |
| Analysis of SARS-CoV-2 isolates, namely the Wuhan strain, Delta variant, and Omicron variant, identifies differential immune profiles S Shahbaz, N Bozorgmehr, J Lu, M Osman, W Sligl, DL Tyrrell, S Elahi Microbiology Spectrum 11 (5), e01256-23, 2023 | 8 | 2023 |
| Transcriptomic profiling of peripheral blood cells in HPV‐associated carcinoma patients receiving combined valproic acid and avelumab N Bozorgmehr, H Syed, S Mashhouri, J Walker, S Elahi Molecular Oncology 18 (5), 1209-1230, 2024 | 3 | 2024 |
| The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2–Infected Individuals with Severe Disease S Saito, N Bozorgmehr, W Sligl, M Osman, S Elahi The Journal of Immunology 212 (10), 1540-1552, 2024 | 1 | 2024 |
| Diverse immunological dysregulation, chronic inflammation, and impaired erythropoiesis in long COVID patients with chronic fatigue syndrome S Saito, S Shahbaz, M Osman, D Redmond, N Bozorgmehr, RJ Rosychuk, ... Journal of Autoimmunity 147, 103267, 2024 | | 2024 |
| Mechanisms of T Cell Dysfunction in Chronic Lymphocytic Leukemia and Viral Associated Carcinoma N Bozorgmehr | | 2023 |
| Immunomodulatory roles of erythroid cells in physiological and pathological conditions S Elahi, G Dunsmore, S Shahbaz, P Koleva, A Namdar, N Bozorgmehr EUROPEAN JOURNAL OF IMMUNOLOGY 49, 569-569, 2019 | | 2019 |
| Erythroid suppressor cells promote feto-maternal tolerance through arginase-2 and PDL-1 S Elahi, C Delyea, N Bozorgmehr, G Dunsmore, S Shahbaz, V Huang The Journal of Immunology 200 (1_Supplement), 118.7-118.7, 2018 | | 2018 |
Dr. Shokrollah ElahiProfessorVerified email at ualberta.ca
Dr. Shokrollah ElahiProfessorVerified email at ualberta.ca